MitoSense

MitoSense, Inc. is a company dedicated to developing treatments for neurodegenerative diseases. Through its research partners based in the United States, the company holds exclusive licensing technology for supplementing human mitochondria using Mitochondrial Organelle Transplantation (MOT™️).